Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Chronic Venous Occlusions Treatment Market

Chronic Venous Occlusions Treatment Market Share

Report ID: GMI5398
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Chronic Venous Occlusions Treatment Market Share

The market is highly fragmented due to the existence of multiple companies. New product releases, mergers and acquisitions, and the inclusion of cutting-edge technologies are among the core strategies being implemented by big corporations to strengthen their market position.

Chronic Venous Occlusions Treatment Market Companies

Some of the eminent market participants operating in the Chronic Venous Occlusions Treatment industry include:

3M Company
Bayer AG
Boston Scientific Corporation
Bristol Myers Squibb
Candela
ConvaTec Inc.
Fotona
Julius Zorn GmbH
Leucadia Pharmaceuticals (Hikma)
Lumenis Ltd.
Manufacturers viz.
Medi GmbH & Co. KG
Medtronic plc
Merz Pharma
Pfizer Inc.
Sanofi
Sciton, Inc
Sigvaris AG
Smith & Nephew PLC
Stryker Corporation
Tactile Medical
Venclose, Inc. (Becton Dickinson and Company)
Viatris Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The chronic venous occlusions treatment industry was valued at USD 6.6 billion in 2023 and is anticipated to witness a CAGR of 5% over 2024-2032, fueled by rising awareness and advancements in medical technologies.

The drugs segment of chronic venous occlusions treatment industry is projected to exceed USD 5.1 billion by 2032, backed by the demand for effective pharmacological treatments, and increased R&D investments in the pharmaceutical industry.

North America chronic venous occlusions treatment market accounted for USD 2.7 billion in revenue in 2023, backed by the high prevalence of chronic venous diseases, such as varicose veins and deep vein thrombosis (DVT), which significantly affect the population.

Boston Scientific Corporation, Bristol Myers Squibb, Candela, ConvaTec Inc., Fotona, Julius Zorn GmbH, Leucadia Pharmaceuticals (Hikma), Lumenis Ltd., Manufacturers viz., Medi GmbH & Co. KG, Medtronic plc, and Merz Pharma.